Some patients with chronic sinusitis develop nasal polyps, which are benign growths that develop within the lining of the nasal passages or sinuses. Some nasal polyps are small and do not cause significant symptoms. However, when nasal polyps grow large enough they can lead to breathing difficulties and loss of smell or taste. Additionally, nasal polyps block the sinus drainage pathways and can lead to sinus infections and facial pain/pressure.
Nasal polyps are most common in adults, especially those with asthma, allergies, or immunodeficiency syndromes. Children with cystic fibrosis are also at higher risk of developing nasal polyps.
Treatment for nasal polyps is often provided initially with medications that can reduce the size of the polyps. Medication may be in the form of pills, nasal sprays, irrigations, or allergy shots. Surgery may be required to remove the polyps if medications are unsuccessful. Endoscopic Sinus Surgery is performed through the nose to remove polyps and re-establish normal sinus drainage pathways. Postoperative medications are then used to attempt to prevent polyp recurrence.
A recent development in sinus surgery is the dissolvable mometasone furoate-releasing stent (PROPEL). Mometasone furoate is the same corticosteroid in Nasonex. Depending on the severity of your nasal polyps and the type of your Sinusitis, your surgeon may place this dissolvable stent into your open ethmoid cavities at the time of surgery that releases mometasone directly to the sinus mucosa in the early postoperative healing period. These stents will self-dissolve or be removed by your surgeon at your first postop visit. These stents are not nasal packing and will not disrupt or block your nasal breathing. The goal of PROPEL is to get your healing off to the right start!